Title
Digital Technology in Movement Disorders: Updates, Applications, and Challenges
Date Issued
01 April 2021
Access level
metadata only access
Resource Type
review
Author(s)
Adams J.L.
Waddell E.M.
Myers T.L.
Jensen-Roberts S.
Modica J.S.
Schneider R.B.
University of Toronto
Publisher(s)
Springer Nature
Abstract
Purpose of Review: Digital technology affords the opportunity to provide objective, frequent, and sensitive assessment of disease outside of the clinic environment. This article reviews recent literature on the application of digital technology in movement disorders, with a focus on Parkinson’s disease (PD) and Huntington’s disease. Recent Findings: Recent research has demonstrated the ability for digital technology to discriminate between individuals with and without PD, identify those at high risk for PD, quantify specific motor features, predict clinical events in PD, inform clinical management, and generate novel insights. Summary: Digital technology has enormous potential to transform clinical research and care in movement disorders. However, more work is needed to better validate existing digital measures, including in new populations, and to develop new more holistic digital measures that move beyond motor features.
Volume
21
Issue
4
Language
English
OCDE Knowledge area
Neurociencias
Scopus EID
2-s2.0-85102024912
PubMed ID
Source
Current Neurology and Neuroscience Reports
ISSN of the container
1528-4042
Sponsor(s)
Dr. Ruth B. Schneider reports grants from the National Institutes of Health, grants from Acadia Pharmaceuticals, grants from Biohaven Pharmaceuticals, grants from The Michael J. Fox Foundation for Parkinson’s Research, grants from CHDI Foundation, grants from Canadian Institute of Health Research, grants from Teva Pharmaceuticals, grants from Pfizer, and grants from Nuredis, Inc., outside the submitted work.
Sources of information: Directorio de Producción Científica Scopus